Louisiana Perinatal Hepatitis B Program
Prevention and Surveillance
The purpose of the Louisiana Perinatal Hepatitis B Program is to eliminate the spread of Hepatitis B virus (HBV) from mother-to-child transmission in the State of Louisiana. CDC recommends that all newborns receive the "birth dose" of the HBV vaccine prior to discharge from the birthing hospital/ birthing facility.
Hepatitis B Virus Statistics and Data
Perinatal screening and universal infant vaccination beginning at birth can prevent infection at all ages. Routine vaccination of previously unvaccinated children and adolescents is an important supplementary intervention until 100% universal vaccine coverage is achieved among infants. The CDC National Quality Forum (NQF) Perinatal Measure #0475 requires each birthing hospital/ birthing facility to measure their administration of a dose of hepatitis B vaccine to all infants born in their hospital/ birthing facility prior to discharge for a specific period.
Louisiana Standard of Care
Reporting Requirements for Hepatitis B VirusAccording to the LAC 51:II.105 (Sanitary Code for the State of Louisiana), Hepatitis B Virus in pregnant women is a Class B Disease. This means that positive cases are required to be reported within 1 business day of receiving a positive lab report. Timely response is necessary because there is great potential for transmission to others.
These cases can be reported to the Louisiana Perinatal Hepatitis B Program either by phone: (504) 838-5300 or by faxing the Perinatal Hepatitis B Surveillance Form found here to (504) 838-5206. According to the Louisiana Sanitary Code Title 51, Ch. II, all laboratories are required to report any of the disease/conditions listed in the Public Health Sanitary Code, Part II, Chapter 1, §105. See "What Laboratories Need to Know"